Acadian Asset Management »

Relmada Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.5M 1.2M 3.00
2023-06-30 $3.0M 1.2M 2.46
2023-03-31 $2.8M 1.2M 2.26
2022-12-31 $3.8M 1.1M 3.48